CompletedPhase 4NCT00494494
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
Studying Cystoid macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of North Carolina, Chapel Hill
- Principal Investigator
- Kenneth C Cohen, MDUniversity of North Carolina, Chapel Hill
- Intervention
- Standard Care(drug)
- Enrollment
- 82 enrolled
- Eligibility
- 50 years · All sexes
- Timeline
- 2007 – 2008
Study locations (1)
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Collaborators
Research to Prevent Blindness
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00494494 on ClinicalTrials.govOther trials for Cystoid macular dystrophy
Additional recruiting or active studies for the same condition.